The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped.

Just a week remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward restricting one of history's deadliest pandemics.

As South Africa is buffeted by criticism from President Donald Trump and other American conservatives—some of it unfair and ...

South Sudan has accepted eight third-country deportees from the U.S. and Rwanda says it’s in talk with the administration of ...

Just before a major HIV vaccine trial was to begin, U.S. funding cuts halted South Africa’s BRILLIANT project, threatening ...

The White House hosted an “African leaders” summit of sorts this week. But only five countries from the continent of more ...

The agency in April warned that a permanent discontinuation of PEPFAR, the massive US effort to fight HIV/Aids, would lead to ...

US President Donald Trump will hold the inaugural African Leaders' Summit of his second term next week in Washington, D.C., ...

Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...

The migrants plan was presented to the presidents of Liberia, Senegal, Guinea-Bissau, Mauritania and Gabon during their visit ...

U.S. President Donald Trump hosts a lunch for African leaders of Gabon, Guinea-Bissau, Liberia, Mauritania, and Senegal in ...